Literature DB >> 22750444

STAT3 repressed USP7 expression is crucial for colon cancer development.

Zhi Yang1, Shoujun Huo, Yuanzhou Shan, Haijun Liu, Yume Xu, Kai Yao, Xianwei Li, Xueli Zhang.   

Abstract

Interleukin-6 (IL-6) induced STAT3 activation is viewed as crucial for multiple tumor growth and metastasis, including colon cancer. However, the molecular mechanisms remain largely unexplored. Here, we show that expression of ubiquitin-specific protease 7 (USP7), a deubiquitylating enzyme, is decreased in STAT3-positive tumors. IL-6 administration or transfection of a constitutively activated STAT3 in SW480 cells also repressed USP mRNA expression. Using luciferase reporter and ChIP assay, we found that STAT3 bound to the promoter region of USP7 and inhibited its activity through recruiting HDAC1. As a result of the decline of USP7 expression, endogenous P53 protein level was decreased. Thus, our results suggest a previously unknown STAT3-USP7-P53 molecular network controlling colon cancer development.
Copyright © 2012 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22750444     DOI: 10.1016/j.febslet.2012.06.025

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  19 in total

1.  Stat3 inhibits Beclin 1 expression through recruitment of HDAC3 in nonsmall cell lung cancer cells.

Authors:  Li-Jun Miao; Feng-Xiang Huang; Zhen-Tao Sun; Rui-Xia Zhang; Shi-Fu Huang; Jing Wang
Journal:  Tumour Biol       Date:  2014-04-24

2.  Divergence in Ubiquitin Interaction and Catalysis among the Ubiquitin-Specific Protease Family Deubiquitinating Enzymes.

Authors:  Adam H Tencer; Qin Liang; Zhihao Zhuang
Journal:  Biochemistry       Date:  2016-08-08       Impact factor: 3.162

3.  Stabilization of the transcription factor Foxp3 by the deubiquitinase USP7 increases Treg-cell-suppressive capacity.

Authors:  Jorg van Loosdregt; Veerle Fleskens; Juan Fu; Arjan B Brenkman; Cornelis P J Bekker; Cornelieke E G M Pals; Jenny Meerding; Celia R Berkers; Joseph Barbi; Andrea Gröne; Alice J A M Sijts; Madelon M Maurice; Eric Kalkhoven; Berent J Prakken; Huib Ovaa; Fan Pan; Dietmar M W Zaiss; Paul J Coffer
Journal:  Immunity       Date:  2013-08-22       Impact factor: 31.745

Review 4.  Nuclear deubiquitination in the spotlight: the multifaceted nature of USP7 biology in disease.

Authors:  Radhika Rawat; Daniel T Starczynowski; Panagiotis Ntziachristos
Journal:  Curr Opin Cell Biol       Date:  2019-03-18       Impact factor: 8.382

Review 5.  Advances in the Development Ubiquitin-Specific Peptidase (USP) Inhibitors.

Authors:  Shiyao Chen; Yunqi Liu; Huchen Zhou
Journal:  Int J Mol Sci       Date:  2021-04-27       Impact factor: 5.923

6.  ω3-PUFAs exert anti-inflammatory activity in visceral adipocytes from colorectal cancer patients.

Authors:  Massimo D'Archivio; Beatrice Scazzocchio; Stefania Giammarioli; Maria L Fiani; Rosaria Varì; Carmela Santangelo; Augusto Veneziani; Annunziata Iacovelli; Claudio Giovannini; Sandra Gessani; Roberta Masella
Journal:  PLoS One       Date:  2013-10-07       Impact factor: 3.240

7.  β1,6 GlcNAc branches-modified PTPRT attenuates its activity and promotes cell migration by STAT3 pathway.

Authors:  Jingjing Qi; Na Li; Kun Fan; Peng Yin; Chao Zhao; Zengxia Li; Yi Lin; Liying Wang; Xiliang Zha
Journal:  PLoS One       Date:  2014-05-20       Impact factor: 3.240

8.  Clinical Significance of Ubiquitin Specific Protease 7 (USP7) in Predicting Prognosis of Hepatocellular Carcinoma and its Functional Mechanisms.

Authors:  Xujing Wang; Qiqi Zhang; Yongkun Wang; Huiren Zhuang; Bo Chen
Journal:  Med Sci Monit       Date:  2018-03-25

9.  IL-6/STAT3 pathway induced deficiency of RFX1 contributes to Th17-dependent autoimmune diseases via epigenetic regulation.

Authors:  Ming Zhao; Yixin Tan; Qiao Peng; Cancan Huang; Yu Guo; Gongping Liang; Bochen Zhu; Yi Huang; Aiyun Liu; Zijun Wang; Mengying Li; Xiaofei Gao; Ruifang Wu; Haijing Wu; Hai Long; Qianjin Lu
Journal:  Nat Commun       Date:  2018-02-08       Impact factor: 14.919

10.  ABRO1 suppresses tumourigenesis and regulates the DNA damage response by stabilizing p53.

Authors:  Jianhong Zhang; Mengmeng Cao; Jiahong Dong; Changyan Li; Wangxiang Xu; Yiqun Zhan; Xiaohui Wang; Miao Yu; Changhui Ge; Zhiqiang Ge; Xiaoming Yang
Journal:  Nat Commun       Date:  2014-10-06       Impact factor: 14.919

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.